Trinity Bio-Tech Coagulation Business Sold to Stago - The Fritsma Factor

Mar 13 2010

George Fritsma

Trinity Bio-Tech of Dublin, Ireland announced Thursday, March 11 the sale of their coagulation business, including manufacture of their Destiny Max coagulometer to Diagnostica Stago, Incorporated of Asnieres, France.

Comments (0)

Posts

No comments here.

Leave a Reply Cancel reply

You must be logged in to post a comment.

George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question